137 related articles for article (PubMed ID: 33357929)
1. Fabrication of tumor-targeting composites based on the triple helical β-glucan through conjugation of aptamer.
Duan B; Zou S; Sun Y; Xu X
Carbohydr Polym; 2021 Feb; 254():117476. PubMed ID: 33357929
[TBL] [Abstract][Full Text] [Related]
2. Lentinan: An unexplored novel biomaterial in drug and gene delivery applications.
Kumar A; Paliwal R; Gulbake A
J Control Release; 2023 Apr; 356():316-336. PubMed ID: 36863692
[TBL] [Abstract][Full Text] [Related]
3. Nanoplatform Constructed from a β-Glucan and Polydeoxyadenylic Acid for Cancer Chemotherapy and Imaging.
Duan B; Zou S; Sun Y; Xu X
Biomacromolecules; 2019 Apr; 20(4):1567-1577. PubMed ID: 30799607
[TBL] [Abstract][Full Text] [Related]
4. Construction of selenium nanoparticles/β-glucan composites for enhancement of the antitumor activity.
Jia X; Liu Q; Zou S; Xu X; Zhang L
Carbohydr Polym; 2015 Mar; 117():434-442. PubMed ID: 25498656
[TBL] [Abstract][Full Text] [Related]
5. A novel gene carrier prepared from triple helical β-glucan and polydeoxyadenylic acid.
Liu Q; Wang C; Cao Y; Xu X; Zhang L
J Mater Chem B; 2014 Feb; 2(8):933-944. PubMed ID: 32261612
[TBL] [Abstract][Full Text] [Related]
6. Transfection efficiency and internalization of the gene carrier prepared from a triple-helical β-glucan and polydeoxyadenylic acid in macrophage RAW264.7 cells.
Liu Q; Xu H; Cao Y; Li M; Xu X; Zhang L
J Mater Chem B; 2015 May; 3(18):3789-3798. PubMed ID: 32262853
[TBL] [Abstract][Full Text] [Related]
7. Assembly of single-stranded polydeoxyadenylic acid and β-glucan probed by the sensing platform of graphene oxide based on the fluorescence resonance energy transfer and fluorescence anisotropy.
Liu Q; Xu X; Zhang L; Luo X; Liang Y
Analyst; 2013 May; 138(9):2661-8. PubMed ID: 23486757
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization and antiviral activity of lentinan from Lentinus edodes mycelia against infectious hematopoietic necrosis virus.
Ren G; Xu L; Lu T; Yin J
Int J Biol Macromol; 2018 Aug; 115():1202-1210. PubMed ID: 29704603
[TBL] [Abstract][Full Text] [Related]
9. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
[TBL] [Abstract][Full Text] [Related]
10. Correlation between antitumor activity, molecular weight, and conformation of lentinan.
Zhang L; Li X; Xu X; Zeng F
Carbohydr Res; 2005 Jun; 340(8):1515-21. PubMed ID: 15882854
[TBL] [Abstract][Full Text] [Related]
11. [Anti tumor activities of lentinan and micellapist in tumor-bearing mice].
Maruyama S; Sukekawa Y; Kaneko Y; Fujimoto S
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1726-9. PubMed ID: 17212088
[TBL] [Abstract][Full Text] [Related]
12. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
[TBL] [Abstract][Full Text] [Related]
13. Lentinan-Functionalized Graphene Oxide Is an Effective Antigen Delivery System That Modulates Innate Immunity and Improves Adaptive Immunity.
Liu Z; He J; Zhu T; Hu C; Bo R; Wusiman A; Hu Y; Wang D
ACS Appl Mater Interfaces; 2020 Sep; 12(35):39014-39023. PubMed ID: 32805921
[TBL] [Abstract][Full Text] [Related]
14. Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration.
Suga Y; Takehana K
Int Immunopharmacol; 2017 Sep; 50():55-60. PubMed ID: 28628771
[TBL] [Abstract][Full Text] [Related]
15. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
16. Local delivery of biocompatible lentinan/chitosan composite for prolonged inhibition of postoperative breast cancer recurrence.
Gu S; Xu J; Teng W; Huang X; Mei H; Chen X; Nie G; Cui Z; Liu X; Zhang Y; Wang K
Int J Biol Macromol; 2022 Jan; 194():233-245. PubMed ID: 34871653
[TBL] [Abstract][Full Text] [Related]
17. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
19. Lentinan produces a robust antidepressant-like effect via enhancing the prefrontal Dectin-1/AMPA receptor signaling pathway.
Bao H; Sun L; Zhu Y; Ran P; Hu W; Zhu K; Li B; Hou Y; Nie J; Gao T; Shan L; Du K; Zheng S; Zheng B; Xiao C; Du J
Behav Brain Res; 2017 Jan; 317():263-271. PubMed ID: 27693847
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
